Literature DB >> 12887055

Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors.

Nobuhiko Katunuma1, Yoichi Matsunaga, Kunisuke Himeno, Yoshio Hayashi.   

Abstract

Eleven human cathepsins have been identified, however, the in vivo roles of individual cathepsins are still largely unknown. In this brief review we will summarize the functions of individual cathepsins in antigen processing and presentation, which are the initial steps of the immune response. Two general inhibitors of papain-like cysteine proteases, E-64 and pyridoxal phosphate, can completely suppress antigen presentation in vivo. To evaluate the contribution of individual cathepsins, specific inhibitors have been developed based on cathepsin tertiary structures: CA-074 for cathepsin B, CLIK-148 and -195 for cathepsin L, CLIK-60 for cathepsin S. Administration of CA-074, a cathepsin B inhibitor, suppresses the response to exogenous antigens, such as hepatitis B virus antigen, ovalbumin and Leishmania major antigen, and induces switching of the helper T cell responses from Th-2 to Th-1 of CD4+ T cells, thereby downregulating the production of IgE and IgG1. Administration of the cathepsin S inhibitor CLIK-60 impairs presentation of an autoantigen, alpha-fodrin, in Sjogren's syndrome and suppresses the Th-1 response and autoantibody production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887055     DOI: 10.1515/BC.2003.099

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  16 in total

1.  Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice.

Authors:  Vivek S Purohit; C Russell Middaugh; Sathyamangalam V Balasubramanian
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

2.  Review of Florida Red Tide and Human Health Effects.

Authors:  Lora E Fleming; Barbara Kirkpatrick; Lorraine C Backer; Cathy J Walsh; Kate Nierenberg; John Clark; Andrew Reich; Julie Hollenbeck; Janet Benson; Yung Sung Cheng; Jerome Naar; Richard Pierce; Andrea J Bourdelais; William M Abraham; Gary Kirkpatrick; Julia Zaias; Adam Wanner; Eliana Mendes; Stuart Shalat; Porter Hoagland; Wendy Stephan; Judy Bean; Sharon Watkins; Tainya Clarke; Margaret Byrne; Daniel G Baden
Journal:  Harmful Algae       Date:  2011-01-01       Impact factor: 4.273

3.  Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.

Authors:  Uta Schurigt; Rene Eilenstein; Mieczyslaw Gajda; Carola Leipner; Lisa Sevenich; Thomas Reinheckel; Christoph Peters; Bernd Wiederanders; Rolf Bräuer
Journal:  Inflamm Res       Date:  2012-06-07       Impact factor: 4.575

4.  Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days.

Authors:  Janet Benson; Fletcher Hahn; Thomas March; Jacob McDonald; Mohan Sopori; JeanClare Seagrave; Andrea Gomez; Andrea Bourdelais; Jerome Naar; Julia Zaias; Gregory Bossart; Daniel Baden
Journal:  J Toxicol Environ Health A       Date:  2004-09-24

5.  Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.

Authors:  Karthik Ramani; Razvan D Miclea; Vivek S Purohit; Donald E Mager; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2008-04       Impact factor: 3.534

6.  CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B.

Authors:  Hiroaki Yoshii; Haruka Kamiyama; Kensuke Goto; Kazunori Oishi; Nobuhiko Katunuma; Yuetsu Tanaka; Hideki Hayashi; Toshifumi Matsuyama; Hironori Sato; Naoki Yamamoto; Yoshinao Kubo
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

7.  Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days.

Authors:  Janet M Benson; Fletcher F Hahn; Thomas H March; Jacob D McDonald; Andrea P Gomez; Mohan J Sopori; Andrea J Bourdelais; Jerome Naar; Julia Zaias; Gregory D Bossart; Daniel G Baden
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

8.  Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.

Authors:  Dana Haves-Zburof; Tamar Paperna; Alumit Gour-Lavie; Ilana Mandel; Lea Glass-Marmor; Ariel Miller
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

9.  Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.

Authors:  Jörg Mengwasser; Liane Babes; Steffen Cordes; Sarah Mertlitz; Katarina Riesner; Yu Shi; Aleixandria McGearey; Martina Kalupa; Thomas Reinheckel; Olaf Penack
Journal:  Front Immunol       Date:  2017-03-01       Impact factor: 7.561

10.  Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).

Authors:  Catherine J Walsh; Stephanie R Leggett; Kathryn Strohbehn; Richard H Pierce; John W Sleasman
Journal:  Mar Drugs       Date:  2008-06-10       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.